AAM Member Fresenius Kabi: Rachel Goode @accessiblemeds
AAM Member Fresenius Kabi: Rachel Goode  @accessiblemeds
Uploaded March 2023 | Updated November 2026, 3 hours ago
Rachel Goode, Senior Vice President, Head of Legal and Intellectual Property, Biosimilars, Fresenius Kabi, on what it means to work in the generics and biosimilars industry. #remarkablygeneric
AAM Member Fresenius Kabi: Rachel GoodeCREATES Act - Its Time to Level the Playing FieldMark Cuban - AAM Access! 2023Protect & Expand CompetitionAAM Member Fresenius Kabi: Fabrice RomanetGeneric Drug Prices vs. Brand Drug PricesAAM All Access - Robert PollockJoin Us at Access! 2023 in Orlando, FloridaFirst Generics Not Available or Covered — #DoesntAddUpSkyrocketing Brand Drug Prices Are a Threat to EveryoneOverview of the EverFi Prescription Drug Abuse Prevention Digital CourseAccess! 2019: Healthcare Leadership Luncheon
Association for Accessible Medicines |

AAM Member Fresenius Kabi: Rachel Goode

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER